Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS – Get Free Report) has been given a consensus rating of “Moderate Buy” by the eight brokerages that are presently covering the firm, MarketBeat.com reports. One investment analyst has rated the stock with a hold recommendation and seven have given a buy recommendation to the company. The average 12-month target price […]
Tarsus Pharmaceuticals (NASDAQ:TARS) Trading 5 8% Higher After Analyst Upgrade tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.
abrdn plc purchased a new position in shares of Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS – Free Report) in the fourth quarter, HoldingsChannel.com reports. The firm purchased 72,032 shares of the company’s stock, valued at approximately $1,459,000. Several other hedge funds have also recently made changes to their positions in TARS. RTW Investments LP boosted its position […]
Tarsus Pharmaceuticals (NASDAQ:TARS – Get Free Report) posted its earnings results on Tuesday. The company reported ($1.31) earnings per share for the quarter, beating the consensus estimate of ($1.37) by $0.06, MarketWatch Earnings reports. The company had revenue of $13.08 million for the quarter, compared to analysts’ expectations of $4.63 million. During the same period […]
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS – Get Free Report)’s share price rose 6.9% during trading on Monday . The company traded as high as $25.14 and last traded at $25.09. Approximately 256,180 shares traded hands during mid-day trading, a decline of 60% from the average daily volume of 644,086 shares. The stock had previously closed at […]